Literature DB >> 22362875

Are measures of body habitus associated with mortality in cystic fibrosis?

Andrew W Fogarty1, John Britton2, Andy Clayton3, Alan R Smyth4.   

Abstract

BACKGROUND: Nutrition is an important component of clinical care for patients with cystic fibrosis. We aimed to test the hypothesis that increased BMI, height, and level of creatinine as a biomarker for lean muscle mass are associated with lower mortality and whether differences in these measures may contribute toward sex differences in survival in cystic fibrosis.
METHODS: Using a cohort study design, we analyzed data from the UK Cystic Fibrosis Registry for patients who attended an annual assessment visit in 2007 and were followed-up until July 2009.
RESULTS: Of 1,517 individuals, 62 died during the follow-up period. The odds of death were higher among patients in the lowest quintile of serum creatinine compared with the rest of the study population (OR, 3.28; 95% CI, 1.79-5.98). Increased height and higher BMI were also associated with lower risk of death. The higher mortality in female patients (OR, 1.48; 95% CI, 0.93-2.34) was reversed by adjustment using the absolute values for height, BMI, and serum creatinine level (adjusted OR, 0.44; 95% CI, 0.21-0.90) but not by the use of sex-specific values for these exposure variables.
CONCLUSIONS: Lower muscle mass, shorter stature, and a low BMI are associated with increased mortality in cystic fibrosis. These measures of body habitus may contribute to the sex-specific survival differences in individuals with cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22362875     DOI: 10.1378/chest.11-2124

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

1.  Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry.

Authors:  Todd MacKenzie; Alex H Gifford; Kathryn A Sabadosa; Hebe B Quinton; Emily A Knapp; Christopher H Goss; Bruce C Marshall
Journal:  Ann Intern Med       Date:  2014-08-19       Impact factor: 25.391

2.  Satisfaction and Concerns with Telemedicine Endocrine Care of Patients with Cystic Fibrosis.

Authors:  Rahat Ahmed; Margaret Greenfield; Christopher P Morley; Marisa Desimone
Journal:  Telemed Rep       Date:  2022-03-21

3.  Gender differences in outcomes of patients with cystic fibrosis.

Authors:  Cayce L Harness-Brumley; Alan C Elliott; Daniel B Rosenbluth; Deepa Raghavan; Raksha Jain
Journal:  J Womens Health (Larchmt)       Date:  2014-12       Impact factor: 2.681

4.  Nutritional Status Improved in Cystic Fibrosis Patients with the G551D Mutation After Treatment with Ivacaftor.

Authors:  Drucy Borowitz; Barry Lubarsky; Michael Wilschanski; Anne Munck; Daniel Gelfond; Frank Bodewes; Sarah Jane Schwarzenberg
Journal:  Dig Dis Sci       Date:  2015-08-07       Impact factor: 3.199

5.  Rate of improvement of CF life expectancy exceeds that of general population--observational death registration study.

Authors:  Matthew N Hurley; Tricia M McKeever; Andrew P Prayle; Andrew W Fogarty; Alan R Smyth
Journal:  J Cyst Fibros       Date:  2014-01-10       Impact factor: 5.482

6.  Exercise capacity and muscle fatiguability alterations following a progressive maximal exercise of lower extremities in children with cystic fibrosis.

Authors:  Walid K Abdelbasset; Gaber S Soliman; Ahmed A Elshehawy; Saud M Alrawaili
Journal:  Afr Health Sci       Date:  2018-12       Impact factor: 0.927

7.  Impact of exacerbations of cystic fibrosis on muscle strength.

Authors:  Chris Burtin; Hans Van Remoortel; Bart Vrijsen; Daniel Langer; Kristine Colpaert; Rik Gosselink; Marc Decramer; Lieven Dupont; Thierry Troosters
Journal:  Respir Res       Date:  2013-04-19

8.  Measures of body habitus are associated with lung function in adults with cystic fibrosis: a population-based study.

Authors:  Doug L Forrester; Alan J Knox; Alan R Smyth; Andrew W Fogarty
Journal:  J Cyst Fibros       Date:  2012-09-05       Impact factor: 5.482

9.  Genetic influences on cystic fibrosis lung disease severity.

Authors:  Colleen A Weiler; Mitchell L Drumm
Journal:  Front Pharmacol       Date:  2013-04-23       Impact factor: 5.810

10.  Weight gain during acute treatment of an initial pulmonary exacerbation is associated with a longer interval to the next exacerbation in adults with cystic fibrosis.

Authors:  Helen L Barr; Miguel Cámara; David Barrett; Paul Williams; Doug Forrester; Alan Smyth; David Honeybourne; Joanna Whitehouse; Edward Nash; Jane Dewar; Alan Knox; Andrew W Fogarty
Journal:  ERJ Open Res       Date:  2017-08-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.